Genmab A/S (ETR:GE9)
Germany
· Delayed Price · Currency is EUR 232.20
+0.30 (0.13%)
At close: Mar 9, 2026
Genmab Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 1,715 | 1,380 | 2,204 | 1,421 | 1,370 | Upgrade
|
| Short-Term Investments | - | 1,574 | 1,967 | 1,786 | 1,588 | Upgrade
|
| Cash & Short-Term Investments | 1,715 | 2,954 | 4,171 | 3,207 | 2,958 | Upgrade
|
| Cash Growth | -41.94% | -29.18% | 30.04% | 8.44% | 11.94% | Upgrade
|
| Accounts Receivable | 1,112 | 923 | 733 | 820.69 | 515 | Upgrade
|
| Other Receivables | 40 | 14 | - | 26.15 | 4.74 | Upgrade
|
| Receivables | 1,152 | 937 | 733 | 846.84 | 519.75 | Upgrade
|
| Inventory | 18 | 9 | 8 | - | - | Upgrade
|
| Total Current Assets | 2,885 | 3,900 | 4,912 | 4,054 | 3,478 | Upgrade
|
| Property, Plant & Equipment | 280 | 265 | 244 | 189.94 | 149.13 | Upgrade
|
| Long-Term Investments | 37 | 32 | 20 | 19.11 | 56.75 | Upgrade
|
| Goodwill | 355 | 355 | - | - | - | Upgrade
|
| Other Intangible Assets | 9,123 | 1,728 | 15 | 20.98 | 38.85 | Upgrade
|
| Long-Term Accounts Receivable | 22 | 7 | 10 | 6.9 | 4.13 | Upgrade
|
| Long-Term Deferred Tax Assets | 171 | 127 | 31 | 36.21 | 40.38 | Upgrade
|
| Total Assets | 12,873 | 6,414 | 5,232 | 4,327 | 3,767 | Upgrade
|
| Accounts Payable | - | - | - | - | 53.53 | Upgrade
|
| Accrued Expenses | - | - | - | - | 45.28 | Upgrade
|
| Current Portion of Long-Term Debt | 273 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 18 | 13 | 13 | 10.63 | 9.48 | Upgrade
|
| Current Income Taxes Payable | 43 | 239 | 8 | - | - | Upgrade
|
| Current Unearned Revenue | 24 | 3 | 5 | 4.74 | 3.98 | Upgrade
|
| Other Current Liabilities | 1,069 | 489 | 342 | 246.55 | 127.57 | Upgrade
|
| Total Current Liabilities | 1,427 | 744 | 368 | 261.93 | 239.84 | Upgrade
|
| Long-Term Debt | 5,001 | - | - | - | - | Upgrade
|
| Long-Term Leases | 134 | 131 | 101 | 75.14 | 55.52 | Upgrade
|
| Long-Term Unearned Revenue | 95 | 67 | 71 | 68.97 | 74.49 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 364 | 330 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 5 | 5 | 5 | 1.58 | 1.99 | Upgrade
|
| Total Liabilities | 7,026 | 1,277 | 545 | 407.62 | 371.84 | Upgrade
|
| Common Stock | 10 | 10 | 10 | 9.48 | 10.1 | Upgrade
|
| Additional Paid-In Capital | 1,920 | 1,961 | 1,942 | 1,769 | 1,840 | Upgrade
|
| Retained Earnings | 4,098 | 3,392 | 2,737 | 2,128 | 1,533 | Upgrade
|
| Comprehensive Income & Other | -181 | -226 | -2 | 14.08 | 12.39 | Upgrade
|
| Shareholders' Equity | 5,847 | 5,137 | 4,687 | 3,920 | 3,395 | Upgrade
|
| Total Liabilities & Equity | 12,873 | 6,414 | 5,232 | 4,327 | 3,767 | Upgrade
|
| Total Debt | 5,426 | 144 | 114 | 85.78 | 65.01 | Upgrade
|
| Net Cash (Debt) | -3,711 | 2,810 | 4,057 | 3,122 | 2,893 | Upgrade
|
| Net Cash Growth | - | -30.74% | 29.96% | 7.91% | 11.69% | Upgrade
|
| Net Cash Per Share | -59.19 | 43.46 | 61.57 | 47.29 | 43.80 | Upgrade
|
| Filing Date Shares Outstanding | 61.62 | 63.54 | 65.33 | 65.37 | 65.43 | Upgrade
|
| Total Common Shares Outstanding | 61.62 | 63.54 | 65.33 | 65.37 | 65.43 | Upgrade
|
| Working Capital | 1,458 | 3,156 | 4,544 | 3,792 | 3,238 | Upgrade
|
| Book Value Per Share | 94.89 | 80.85 | 71.74 | 59.96 | 51.89 | Upgrade
|
| Tangible Book Value | -3,631 | 3,054 | 4,672 | 3,899 | 3,356 | Upgrade
|
| Tangible Book Value Per Share | -58.93 | 48.06 | 71.51 | 59.64 | 51.29 | Upgrade
|
| Machinery | 175 | 139 | 135 | 93.25 | 82.14 | Upgrade
|
| Construction In Progress | 3 | 14 | 6 | 33.48 | 7.95 | Upgrade
|
| Leasehold Improvements | 132 | 101 | 101 | 59.2 | 61.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.